Fahd Quddus, MBBS

Fahd Quddus practices at Bon Secours St. Francis Downtown in Greenville, South Carolina, part of Bon Secours Mercy Health.

Fahd Quddus' NPI, 1952530677, was assigned on July 2, 2009. Fahd Quddus holds Nebraska license 5899.

Fahd Quddus' primary practice is Bon Secours St. Francis Downtown, at One St Francis Dr, Greenville, SC 29601 in Greenville County. The practice phone is (800) 805-5678. Fahd Quddus also practices at St Francis - Downtown, 1 St Francis Dr, Greenville, SC 29601.

Fahd Quddus' primary practice is Bon Secours St. Francis Downtown in Greenville, South Carolina, part of Bon Secours Mercy Health. The medical group on file is Bon Secours Medical Group Greenville Specialty Care. Dmand AI also links Fahd Quddus to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Fahd Quddus practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Fahd Quddus' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Fahd Quddus is licensed in Nebraska.

CMS data shows 629 Medicare services from Fahd Quddus across 6 procedure codes in 2024, for 324 Medicare patients. Medicare paid $60,020 for them.

CMS counts 324 Medicare patients who saw Fahd Quddus in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Fahd Quddus' median patient age at 70, with 55% women.

In 2024, Fahd Quddus wrote 1,202 Medicare Part D claims for 179 patients. 66% of them were for generic drugs. CMS names the drug for 873 of them, across 32 drugs with 11 or more claims each, at $2,485,972 in total drug cost. In 2023, CMS named 864 claims across 31 drugs.

Fahd Quddus accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Fahd Quddus in 2014. Fahd Quddus' most frequent co-authors are Matthew James Butler, MD and Ming Yin, MD.

Dmand AI links Fahd Quddus to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 197 general payments to Fahd Quddus from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,152.